{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:57:43Z","timestamp":1790989063829,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2026JJ80465"],"award-info":[{"award-number":["2026JJ80465"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.bbadis.2026.168408","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T23:28:48Z","timestamp":1786750128000},"page":"168408","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["KLHL1 suppresses triple-negative breast cancer progression by promoting M1 macrophage polarization via APOC2 degradation"],"prefix":"10.1016","volume":"1873","author":[{"given":"Ziran","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ce","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MengXue","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2026.168408_bb0005","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbadis.2026.168408_bb0010","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-023-06383-x","article-title":"TRIM21-mediated Sohlh2 ubiquitination suppresses M2 macrophage polarization and progression of triple-negative breast cancer","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168408_bb0015","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2364382","article-title":"HUNK as a key regulator of tumor-associated macrophages in triple negative breast cancer","volume":"13","author":"Ramos Solis","year":"2024","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbadis.2026.168408_bb0020","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.737982","article-title":"Intraoperative radiotherapy is not a better alternative to whole breast radiotherapy as a therapeutic option for early-stage breast cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0025","article-title":"Risk prediction in early triple negative breast cancer","volume":"387","author":"Mason","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.bbadis.2026.168408_bb0030","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/jama.2024.26886","article-title":"Adjuvant atezolizumab for early triple-negative breast cancer: the ALEXANDRA\/IMpassion030 randomized clinical trial","volume":"333","author":"Ignatiadis","year":"2025","journal-title":"Jama"},{"key":"10.1016\/j.bbadis.2026.168408_bb0035","article-title":"Inhibiting NEDD4 in triple-negative breast cancer cells reprograms tumor immune microenvironment via the \u03b2-TrCP\/YAP\/ECM axis","volume":"6","author":"Su","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bbadis.2026.168408_bb0040","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14728222.2022.2170779","article-title":"The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting","volume":"26","author":"Furukawa","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bbadis.2026.168408_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232314937","article-title":"Genetic heterogeneity, tumor microenvironment and immunotherapy in triple-negative breast cancer","volume":"23","author":"Kudelova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbadis.2026.168408_bb0050","article-title":"Roles of tumor-associated macrophages in triple-negative breast cancer progression","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0055","article-title":"Roles of tumor-associated macrophages in triple-negative breast cancer progression","volume":"16","author":"Tianhai Wu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2024.155458","article-title":"M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1","volume":"260","author":"Zhang","year":"2024","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.bbadis.2026.168408_bb0065","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.13900","article-title":"Jianpi-Tiaoqi decoction inhibits tumour proliferation and lung metastasis in tumour-bearing mice with triple-negative breast cancer","volume":"51","author":"Zhang","year":"2024","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0070","article-title":"Alpha fetoprotein promotes polarization of macrophages towards M2-like phenotype and inhibits macrophages to phagocytize hepatoma cells","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0075","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.cmet.2024.10.002","article-title":"Hexokinase 2 senses fructose in tumor-associated macrophages to promote colorectal cancer growth","volume":"36","author":"Yan","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2026.168408_bb0080","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1177\/00220345211059418","article-title":"Leptin aggravates periodontitis by promoting M1 polarization via NLRP3","volume":"101","author":"Han","year":"2022","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.bbadis.2026.168408_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189478","article-title":"Role of macrophage PKM2 in inflammation and tumor progression and its targeted therapy","volume":"1880","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168408_bb0090","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s13578-023-01153-w","article-title":"The Streptococcus virulence protein PepO triggers anti-tumor immune responses by reprograming tumor-associated macrophages in a mouse triple negative breast cancer model","volume":"13","author":"Liu","year":"2023","journal-title":"Cell Biosci."},{"key":"10.1016\/j.bbadis.2026.168408_bb0095","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1002\/jcp.29506","article-title":"miR-4510 acts as a tumor suppressor in gastrointestinal stromal tumor by targeting APOC2","volume":"235","author":"Chen","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0100","article-title":"Lactylated apolipoprotein C-II induces immunotherapy resistance by promoting extracellular lipolysis","volume":"11","author":"Chen","year":"2024","journal-title":"Adv. Sci. (Weinh)."},{"key":"10.1016\/j.bbadis.2026.168408_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107521","article-title":"EVA1B facilitates esophageal squamous carcinoma progression and recruitment of immunosuppressive myeloid-derived suppressor cells in the tumor microenvironment","volume":"210","author":"Xia","year":"2024","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bbadis.2026.168408_bb0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2025.02.002","article-title":"Reshaping the immune microenvironment and reversing immunosenescence by natural products: prospects for immunotherapy in gastric cancer","volume":"110","author":"Cao","year":"2025","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0115","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1093\/cvr\/cvab237","article-title":"Interleukin-5-induced eosinophil population improves cardiac function after myocardial infarction","volume":"118","author":"Xu","year":"2022","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bbadis.2026.168408_bb0120","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2022.5374","article-title":"Roles of ubiquitination in the crosstalk between tumors and the tumor microenvironment (review)","volume":"61","author":"Zhang","year":"2022","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0125","first-page":"2970","article-title":"Ubiquitin-proteasome system-mediated ubiquitination modification patterns and characterization of tumor microenvironment infiltration, stemness and cellular senescence in low-grade glioma","volume":"15","author":"Gu","year":"2023","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbadis.2026.168408_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2022.100971","article-title":"Exploiting the ubiquitin system in myeloid malignancies. From basic research to drug discovery in MDS and AML","volume":"56","author":"Drula","year":"2022","journal-title":"Blood Rev."},{"key":"10.1016\/j.bbadis.2026.168408_bb0135","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/jmcb\/mjx007","article-title":"The role of MDM2 and MDM4 in breast cancer development and prevention","volume":"9","author":"Haupt","year":"2017","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12935-024-03563-3","article-title":"E3 ubiquitin ligase HECW2: a promising target for tumour therapy","volume":"24","author":"Shen","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2026.168408_bb0145","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s10495-024-01957-2","article-title":"ARTS and small-molecule ARTS mimetics upregulate p53 levels by promoting the degradation of XIAP","volume":"29","author":"Abbas","year":"2024","journal-title":"Apoptosis"},{"key":"10.1016\/j.bbadis.2026.168408_bb0150","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41419-021-03888-1","article-title":"PRDX2 promotes the proliferation of colorectal cancer cells by increasing the ubiquitinated degradation of p53","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168408_bb0155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s40164-024-00552-0","article-title":"Ubiquitin modification in the regulation of tumor immunotherapy resistance mechanisms and potential therapeutic targets","volume":"13","author":"Hong","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2016.00007","article-title":"Clinical overview of MDM2\/X-targeted therapies","volume":"6","author":"Burgess","year":"2016","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0165","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.molmed.2023.05.006","article-title":"The ubiquitin-proteasome system in breast cancer","volume":"29","author":"Han","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.bbadis.2026.168408_bb0170","doi-asserted-by":"crossref","DOI":"10.1038\/srep40144","article-title":"Predictive screening of M1 and M2 macrophages reveals the immunomodulatory effectiveness of post spinal cord injury azithromycin treatment","volume":"7","author":"Gensel","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2026.168408_bb0175","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-002022","article-title":"Effect of cabazitaxel on macrophages improves CD47-targeted immunotherapy for triple-negative breast cancer","volume":"9","author":"Cao","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2026.168408_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12014-019-9262-0","article-title":"The plasma peptides of breast versus ovarian cancer","volume":"16","author":"Dufresne","year":"2019","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.bbadis.2026.168408_bb0185","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009548","article-title":"Antibodies against the multifaceted cathepsin D protein open new avenues for TNBC immunotherapy","volume":"13","author":"Desroys du Roure","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.bbadis.2026.168408_bb0190","article-title":"Improving efficacy of TNBC immunotherapy: based on analysis and subtyping of immune microenvironment","volume":"15","author":"Yang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0195","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.406","article-title":"Deregulation of apolipoprotein C2 gene in cancer: a potential metabolic vulnerability","volume":"11","author":"Liu","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168408_bb0200","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.semcdb.2023.08.002","article-title":"Proteotoxic stress and the ubiquitin proteasome system","volume":"156","author":"Kandel","year":"2024","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0205","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbadis.2026.168408_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188679","article-title":"E2-E3 ubiquitin enzyme pairing - partnership in provoking or mitigating cancers","volume":"1877","author":"Chang","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.bbadis.2026.168408_bb0215","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/s41419-024-06888-z","article-title":"Biological impact and therapeutic implication of tumor-associated macrophages in hepatocellular carcinoma","volume":"15","author":"Li","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbadis.2026.168408_bb0220","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0225","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2022.2085432","article-title":"Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.bbadis.2026.168408_bb0230","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s12935-024-03481-4","article-title":"Lipid metabolism associated crosstalk: the bidirectional interaction between cancer cells and immune\/stromal cells within the tumor microenvironment for prognostic insight","volume":"24","author":"Lin","year":"2024","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbadis.2026.168408_bb0235","article-title":"Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.bbadis.2026.168408_bb0240","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ijbiomac.2021.11.183","article-title":"Functional analysis and regulation mechanism of interferon gamma in macrophages of large yellow croaker (Larimichthys crocea)","volume":"194","author":"Xu","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0245","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158758","article-title":"Axl promotes intracranial aneurysm rupture by regulating macrophage polarization toward M1 via STAT1\/HIF-1\u03b1","volume":"14","author":"Han","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bbadis.2026.168408_bb0250","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102570","article-title":"Near-infrared-light remote-controlled activation of cancer immunotherapy using photothermal conjugated polymer nanoparticles","volume":"33","author":"Fu","year":"2021","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbadis.2026.168408_bb0255","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00262-022-03343-w","article-title":"CXCL9 influences the tumor immune microenvironment by stimulating JAK\/STAT pathway in triple-negative breast cancer","volume":"72","author":"Wu","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.bbadis.2026.168408_bb0260","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1002\/mc.70003","article-title":"M1 macrophage extracellular vesicles and TLR3 agonist nanoparticles down-regulate immunosuppression and metastasis via AKT\/TAM in triple-negative breast cancer","volume":"64","author":"Souza","year":"2025","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.bbadis.2026.168408_bb0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.21147\/j.issn.1000-9604.2025.02.10","article-title":"Immune cell-derived exosomal non-coding RNAs in tumor microenvironment: biological functions and potential clinical applications","volume":"37","author":"Liu","year":"2025","journal-title":"Chin. J. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443926002711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:32Z","timestamp":1790987132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443926002711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2027,1]]}},"alternative-id":["S0925443926002711"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168408","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLHL1 suppresses triple-negative breast cancer progression by promoting M1 macrophage polarization via APOC2 degradation","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2026.168408","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"168408"}}